UK markets closed

Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
13.69+0.11 (+0.81%)
At close: 04:00PM EDT
13.50 -0.19 (-1.39%)
After hours: 04:59PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts20202121
Avg. Estimate-1.67-1.6-6.47-4.87
Low estimate-2.04-1.9-7.36-7.53
High estimate-1.17-0.99-4.853.59
Year ago EPS-2.68-3.37-9.05-6.47
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts17171921
Avg. Estimate8.06M10.15M38.08M134.9M
Low estimate4.94M5.32M21.04M51M
High estimate13.9M17.9M59.9M584.56M
Year ago sales2.47M2.72M86.45M38.08M
Sales growth (year/est)226.30%273.70%-56.00%254.30%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-2.55-2.73-1.28-1.65
Actual EPS-2.68-3.37-0.55-1.8
Difference-0.13-0.640.73-0.15
Surprise %-5.10%-23.40%57.00%-9.10%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.67-1.6-6.47-4.87
7 days ago-1.64-1.62-6.39-4.84
30 days ago-1.6-1.58-6.25-4.73
60 days ago-1.58-1.57-6.3-4.9
90 days ago-1.74-1.7-6.14-5.24
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days3644
Up last 30 days3646
Down last 7 daysN/AN/AN/AN/A
Down last 30 days119127
Growth estimatesSAGEIndustrySector(s)S&P 500
Current qtr.37.70%N/AN/AN/A
Next qtr.52.50%N/AN/AN/A
Current year28.50%N/AN/AN/A
Next year24.70%N/AN/AN/A
Next 5 years (per annum)16.80%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A